Cargando…

Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors

OBJECTIVES: The aim of our study was to describe the incidence and predictive factors of secondary infections in patients with coronavirus disease 2019 (COVID-19). METHODS: This was a cohort study of patients hospitalized with COVID-19 at IRCCS San Raffaele Hospital between 25th February and 6th Apr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ripa, Marco, Galli, Laura, Poli, Andrea, Oltolini, Chiara, Spagnuolo, Vincenzo, Mastrangelo, Andrea, Muccini, Camilla, Monti, Giacomo, De Luca, Giacomo, Landoni, Giovanni, Dagna, Lorenzo, Clementi, Massimo, Rovere Querini, Patrizia, Ciceri, Fabio, Tresoldi, Moreno, Lazzarin, Adriano, Zangrillo, Alberto, Scarpellini, Paolo, Castagna, Antonella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584496/ https://www.ncbi.nlm.nih.gov/pubmed/33223114 http://dx.doi.org/10.1016/j.cmi.2020.10.021

Ejemplares similares

Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19
por: Spagnuolo, V., et al.
Publicado: (2021)

Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19
por: Spagnuolo, V., et al.
Publicado: (2020)

505. Impact of Remdesivir on SARS-CoV-2 Clearance in a Real-Life Setting: A Matched-Cohort Study
por: Spagnuolo, Vincenzo, et al.
Publicado: (2021)

Impact of Remdesivir on SARS-CoV-2 Clearance in a Real-Life Setting: A Matched-Cohort Study
por: Spagnuolo, Vincenzo, et al.
Publicado: (2022)

Efficacy and safety of switching from branded to generic antiretrovirals in virologically suppressed HIV-infected patients
por: Gianotti, Nicola, et al.
Publicado: (2017)

Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study
por: Cavalli, Giulio, et al.
Publicado: (2021)

High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19
por: Ripa, Marco, et al.
Publicado: (2022)

Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy
por: Ciceri, Fabio, et al.
Publicado: (2020)

Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study
por: Campochiaro, Corrado, et al.
Publicado: (2020)

Pulmonary Vascular Thrombosis in COVID-19 Pneumonia
por: De Cobelli, Francesco, et al.
Publicado: (2021)

Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study
por: Cavalli, Giulio, et al.
Publicado: (2020)

Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation
por: Della-Torre, Emanuel, et al.
Publicado: (2021)

Coronavirus Disease 2019 in Recipient of Allogeneic Hematopoietic Stem Cell Transplantation: Life-threating Features Within the Early Post-engraftment Phase
por: Oltolini, Chiara, et al.
Publicado: (2020)

Achieving virological control in pan-resistant HIV-1 infection: A case series
por: Canetti, Diana, et al.
Publicado: (2022)

Durability of switch regimens based on rilpivirine or on integrase inhibitors, both in association with tenofovir and emtricitabine, in HIV-infected, virologically suppressed patients
por: Gianotti, Nicola, et al.
Publicado: (2017)

Association between low levels of HIV-1 DNA and HLA class I molecules in chronic HIV-1 infection
por: Muccini, Camilla, et al.
Publicado: (2022)

Residual clinical damage after COVID-19: A retrospective and prospective observational cohort study
por: De Lorenzo, Rebecca, et al.
Publicado: (2020)

Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis
por: Ciceri, Fabio, et al.
Publicado: (2023)

2408. Is Shorter Antibiotic Treatment Feasible in Patients with Cardiac Implantable Electronic Devices (CIED) Infections? Impact of Treatment Duration on 6-Month Recurrence and Mortality
por: Ponta, Giacomo, et al.
Publicado: (2023)

Increasing incidence and prevalence of metabolic syndrome in people living with HIV during the COVID-19 pandemic
por: Papaioannu Borjesson, Rebecka, et al.
Publicado: (2023)

Efficacy and Safety Profile of Fostemsavir for the Treatment of People with Human Immunodeficiency Virus-1 (HIV-1): Current Evidence and Place in Therapy
por: Muccini, Camilla, et al.
Publicado: (2022)

Estimated Glomerular Filtration Rate Trajectories in HIV-Infected Subjects Treated With Different Ritonavir-Boosted Protease Inhibitors and Tenofovir Disoproxil Fumarate or Abacavir
por: Gianotti, Nicola, et al.
Publicado: (2016)

Fast reshaping of intensive care unit facilities in a large metropolitan hospital in Milan, Italy: facing the COVID-19 pandemic emergency
por: Zangrillo, Alberto, et al.
Publicado: (2023)

GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort study
por: De Luca, Giacomo, et al.
Publicado: (2020)

Switching from a Non-Protease inhibitor-Based Regimen To the Fixed Dose Combination of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Clinical Practice
por: Ranzenigo, Martina, et al.
Publicado: (2022)

Cost analysis of initial highly active antiretroviral therapy regimens for managing human immunodeficiency virus-infected patients according to clinical practice in a hospital setting
por: Colombo, Giorgio L, et al.
Publicado: (2013)

Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label cohort study
por: Della-Torre, Emanuel, et al.
Publicado: (2020)

Predictors of lack of serological response to syphilis treatment in HIV-infected subjects
por: Spagnuolo, Vincenzo, et al.
Publicado: (2014)

Associations of statins and antiretroviral drugs with the onset of type 2 diabetes among HIV-1-infected patients
por: Spagnuolo, Vincenzo, et al.
Publicado: (2017)

A nucleoside-sparing regimen of dolutegravir plus ritonavir-boosted atazanavir in HIV-1-infected patients with virological failure: the DOLATAV study
por: Spagnuolo, Vincenzo, et al.
Publicado: (2019)

A radiological predictor for pneumomediastinum/pneumothorax in COVID-19 ARDS patients
por: Palumbo, Diego, et al.
Publicado: (2021)

Combined plasma levels of IL‐10 and testosterone, but not soluble HLA‐G5, predict the risk of death in COVID‐19 patients
por: Amodio, Giada, et al.
Publicado: (2022)

Efficacy and safety in clinical practice of a rilpivirine, tenofovir and emtricitabine single-tablet regimen in virologically suppressed HIV-positive patients on stable antiretroviral therapy
por: Gianotti, Nicola, et al.
Publicado: (2015)

Incidence and Predictors of Serological Treatment Response in Early and Late Syphilis Among People Living With HIV
por: Spagnuolo, Vincenzo, et al.
Publicado: (2018)

Can Cytokine Blocking Prevent Depression in COVID-19 Survivors?
por: Benedetti, Francesco, et al.
Publicado: (2020)

Correction to: Can Cytokine Blocking Prevent Depression in COVID-19 Survivors?
por: Benedetti, Francesco, et al.
Publicado: (2021)

Epicardial adipose tissue characteristics, obesity and clinical outcomes in COVID-19: A post-hoc analysis of a prospective cohort study
por: Conte, Caterina, et al.
Publicado: (2021)

Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in Milan, Italy
por: Zangrillo, Alberto, et al.
Publicado: (2023)

Initial chest radiographs and artificial intelligence (AI) predict clinical outcomes in COVID-19 patients: analysis of 697 Italian patients
por: Mushtaq, Junaid, et al.
Publicado: (2020)

Hypocalcemia is highly prevalent and predicts hospitalization in patients with COVID-19
por: Di Filippo, Luigi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9tfc93j61jvd43f6kvke7avb8q